(CWK) Cushman & Wakefield - Overview
Sector: Real EstateIndustry: Real Estate Services | Exchange NYSE (USA) | Currency USD | Market Cap: 2.798m | Total Return 12.7% in 12m
Stock: Real Estate, Property Management, Consulting
Total Rating 41
Risk 77
Buy Signal -0.90
| Risk 5d forecast | |
|---|---|
| Volatility | 44.1% |
| Relative Tail Risk | -12.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.40 |
| Alpha | -7.59 |
| Character TTM | |
|---|---|
| Beta | 1.677 |
| Beta Downside | 1.851 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.97% |
| CAGR/Max DD | 0.08 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
choppy
Description: CWK Cushman & Wakefield March 04, 2026
Cushman & Wakefield plc (CWK) provides commercial real estate services globally, operating in the Americas, Europe, Middle East, Africa, and Asia Pacific. Real estate services are a cyclical industry, sensitive to economic conditions and interest rate fluctuations.
The companys services include integrated facilities management, project and development services, and portfolio administration. Cushman & Wakefield also offers property management, including client accounting and sustainability services. This business model often relies on long-term contracts for recurring revenue.
Further offerings include self-performed facilities services like janitorial and maintenance, as well as project management and workplace consulting. CWK provides leasing services for both owners and tenants, and debt and structured financing for real estate transactions.
The firm also specializes in appraisal management, investment management, and valuation advisory services for real estate debt and equity decisions. Its clientele includes real estate owners, occupiers, tenants, investors, and multinational corporations. The company was founded in 1784.
To gain deeper insights into CWKs performance and market position, consider exploring its detailed financials on platforms like ValueRay.
Headlines to watch out for
- Commercial real estate transaction volumes impact brokerage fees
- Interest rate hikes reduce commercial property valuations
- Global economic growth influences corporate real estate demand
- Office occupancy rates affect property management revenue
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 88.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.79 > 1.0 |
| NWC/Revenue: 26.42% < 20% (prev 3.82%; Δ 22.60% < -1%) |
| CFO/TA 0.04 > 3% & CFO 340.4m > Net Income 88.2m |
| Net Debt (2.46b) to EBITDA (421.8m): 5.83 < 3 |
| Current Ratio: 22.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (237.0m) vs 12m ago 1.02% < -2% |
| Gross Margin: 17.27% > 18% (prev 0.18%; Δ 1.71k% > 0.5%) |
| Asset Turnover: 135.1% > 50% (prev 125.1%; Δ 10.01% > 0%) |
| Interest Coverage Ratio: 1.47 > 6 (EBITDA TTM 421.8m / Interest Expense TTM 216.2m) |
Altman Z'' 2.02
| A: 0.35 (Total Current Assets 2.84b - Total Current Liabilities 124.9m) / Total Assets 7.68b |
| B: -0.12 (Retained Earnings -897.7m / Total Assets 7.68b) |
| C: 0.04 (EBIT TTM 317.6m / Avg Total Assets 7.61b) |
| D: -0.19 (Book Value of Equity -1.08b / Total Liabilities 5.72b) |
| Altman-Z'' Score: 2.02 = BBB |
Beneish M -2.93
| DSRI: 1.03 (Receivables 1.52b/1.35b, Revenue 10.29b/9.45b) |
| GMI: 1.06 (GM 17.27% / 18.27%) |
| AQI: 0.98 (AQ_t 0.58 / AQ_t-1 0.59) |
| SGI: 1.09 (Revenue 10.29b / 9.45b) |
| TATA: -0.03 (NI 88.2m - CFO 340.4m) / TA 7.68b) |
| Beneish M-Score: -2.93 (Cap -4..+1) = A |
What is the price of CWK shares?
As of March 29, 2026, the stock is trading at USD 11.80 with a total of 934,524 shares traded.
Over the past week, the price has changed by -0.34%, over one month by -12.01%, over three months by -28.61% and over the past year by +12.70%.
Over the past week, the price has changed by -0.34%, over one month by -12.01%, over three months by -28.61% and over the past year by +12.70%.
Is CWK a buy, sell or hold?
Cushman & Wakefield has received a consensus analysts rating of 3.40.
Therefor, it is recommend to hold CWK.
- StrongBuy: 1
- Buy: 3
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the CWK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 17.8 | 50.4% |
| Analysts Target Price | 17.8 | 50.4% |
CWK Fundamental Data Overview March 28, 2026
P/E Trailing = 31.7632
P/E Forward = 11.8343
P/S = 0.272
P/B = 1.4038
P/EG = 0.5333
Revenue TTM = 10.29b USD
EBIT TTM = 317.6m USD
EBITDA TTM = 421.8m USD
Long Term Debt = 2.62b USD (from longTermDebt, last quarter)
Short Term Debt = 124.9m USD (from shortTermDebt, last quarter)
Debt = 3.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.46b USD (from netDebt column, last quarter)
Enterprise Value = 5.26b USD (2.80b + Debt 3.24b - CCE 784.2m)
Interest Coverage Ratio = 1.47 (Ebit TTM 317.6m / Interest Expense TTM 216.2m)
EV/FCF = 17.13x (Enterprise Value 5.26b / FCF TTM 306.9m)
FCF Yield = 5.84% (FCF TTM 306.9m / Enterprise Value 5.26b)
FCF Margin = 2.98% (FCF TTM 306.9m / Revenue TTM 10.29b)
Net Margin = 0.86% (Net Income TTM 88.2m / Revenue TTM 10.29b)
Gross Margin = 17.27% ((Revenue TTM 10.29b - Cost of Revenue TTM 8.51b) / Revenue TTM)
Gross Margin QoQ = 17.97% (prev 16.43%)
Tobins Q-Ratio = 0.68 (Enterprise Value 5.26b / Total Assets 7.68b)
Interest Expense / Debt = 1.69% (Interest Expense 54.7m / Debt 3.24b)
Taxrate = 22.77% (26.0m / 114.2m)
NOPAT = 245.3m (EBIT 317.6m * (1 - 22.77%))
Current Ratio = 22.76 (Total Current Assets 2.84b / Total Current Liabilities 124.9m)
Debt / Equity = 1.66 (Debt 3.24b / totalStockholderEquity, last quarter 1.96b)
Debt / EBITDA = 5.83 (Net Debt 2.46b / EBITDA 421.8m)
Debt / FCF = 8.01 (Net Debt 2.46b / FCF TTM 306.9m)
Total Stockholder Equity = 1.90b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.16% (Net Income 88.2m / Total Assets 7.68b)
RoE = 4.65% (Net Income TTM 88.2m / Total Stockholder Equity 1.90b)
RoCE = 7.02% (EBIT 317.6m / Capital Employed (Equity 1.90b + L.T.Debt 2.62b))
RoIC = 5.11% (NOPAT 245.3m / Invested Capital 4.80b)
WACC = 6.20% (E(2.80b)/V(6.04b) * Re(11.88%) + D(3.24b)/V(6.04b) * Rd(1.69%) * (1-Tc(0.23)))
Discount Rate = 11.88% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.75%
[DCF] Terminal Value 81.91% ; FCFF base≈250.9m ; Y1≈188.7m ; Y5≈113.1m
[DCF] Fair Price = 3.58 (EV 3.29b - Net Debt 2.46b = Equity 829.3m / Shares 231.8m; r=6.20% [WACC]; 5y FCF grow -29.41% → 3.0% )
EPS Correlation: -16.53 | EPS CAGR: 3.19% | SUE: 0.01 | # QB: 0
Revenue Correlation: 23.74 | Revenue CAGR: 6.13% | SUE: 1.47 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.34 | Chg7d=+0.000 | Chg30d=+0.006 | Revisions Net=+1 | Analysts=9
EPS current Year (2026-12-31): EPS=1.45 | Chg7d=+0.000 | Chg30d=-0.005 | Revisions Net=-1 | Growth EPS=+19.1% | Growth Revenue=+5.4%
EPS next Year (2027-12-31): EPS=1.70 | Chg7d=+0.004 | Chg30d=-0.003 | Revisions Net=+1 | Growth EPS=+16.8% | Growth Revenue=+6.2%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.7% (Discount Rate 11.9% - Earnings Yield 3.1%)
[Growth] Growth Spread = -3.4% (Analyst 5.3% - Implied 8.7%)
P/E Forward = 11.8343
P/S = 0.272
P/B = 1.4038
P/EG = 0.5333
Revenue TTM = 10.29b USD
EBIT TTM = 317.6m USD
EBITDA TTM = 421.8m USD
Long Term Debt = 2.62b USD (from longTermDebt, last quarter)
Short Term Debt = 124.9m USD (from shortTermDebt, last quarter)
Debt = 3.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.46b USD (from netDebt column, last quarter)
Enterprise Value = 5.26b USD (2.80b + Debt 3.24b - CCE 784.2m)
Interest Coverage Ratio = 1.47 (Ebit TTM 317.6m / Interest Expense TTM 216.2m)
EV/FCF = 17.13x (Enterprise Value 5.26b / FCF TTM 306.9m)
FCF Yield = 5.84% (FCF TTM 306.9m / Enterprise Value 5.26b)
FCF Margin = 2.98% (FCF TTM 306.9m / Revenue TTM 10.29b)
Net Margin = 0.86% (Net Income TTM 88.2m / Revenue TTM 10.29b)
Gross Margin = 17.27% ((Revenue TTM 10.29b - Cost of Revenue TTM 8.51b) / Revenue TTM)
Gross Margin QoQ = 17.97% (prev 16.43%)
Tobins Q-Ratio = 0.68 (Enterprise Value 5.26b / Total Assets 7.68b)
Interest Expense / Debt = 1.69% (Interest Expense 54.7m / Debt 3.24b)
Taxrate = 22.77% (26.0m / 114.2m)
NOPAT = 245.3m (EBIT 317.6m * (1 - 22.77%))
Current Ratio = 22.76 (Total Current Assets 2.84b / Total Current Liabilities 124.9m)
Debt / Equity = 1.66 (Debt 3.24b / totalStockholderEquity, last quarter 1.96b)
Debt / EBITDA = 5.83 (Net Debt 2.46b / EBITDA 421.8m)
Debt / FCF = 8.01 (Net Debt 2.46b / FCF TTM 306.9m)
Total Stockholder Equity = 1.90b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.16% (Net Income 88.2m / Total Assets 7.68b)
RoE = 4.65% (Net Income TTM 88.2m / Total Stockholder Equity 1.90b)
RoCE = 7.02% (EBIT 317.6m / Capital Employed (Equity 1.90b + L.T.Debt 2.62b))
RoIC = 5.11% (NOPAT 245.3m / Invested Capital 4.80b)
WACC = 6.20% (E(2.80b)/V(6.04b) * Re(11.88%) + D(3.24b)/V(6.04b) * Rd(1.69%) * (1-Tc(0.23)))
Discount Rate = 11.88% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.75%
[DCF] Terminal Value 81.91% ; FCFF base≈250.9m ; Y1≈188.7m ; Y5≈113.1m
[DCF] Fair Price = 3.58 (EV 3.29b - Net Debt 2.46b = Equity 829.3m / Shares 231.8m; r=6.20% [WACC]; 5y FCF grow -29.41% → 3.0% )
EPS Correlation: -16.53 | EPS CAGR: 3.19% | SUE: 0.01 | # QB: 0
Revenue Correlation: 23.74 | Revenue CAGR: 6.13% | SUE: 1.47 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.34 | Chg7d=+0.000 | Chg30d=+0.006 | Revisions Net=+1 | Analysts=9
EPS current Year (2026-12-31): EPS=1.45 | Chg7d=+0.000 | Chg30d=-0.005 | Revisions Net=-1 | Growth EPS=+19.1% | Growth Revenue=+5.4%
EPS next Year (2027-12-31): EPS=1.70 | Chg7d=+0.004 | Chg30d=-0.003 | Revisions Net=+1 | Growth EPS=+16.8% | Growth Revenue=+6.2%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.7% (Discount Rate 11.9% - Earnings Yield 3.1%)
[Growth] Growth Spread = -3.4% (Analyst 5.3% - Implied 8.7%)